
Johnson & Johnson
JNJ 259.10 (-1.82%) 4.71
Health Care
Pharmaceuticals
Quality Checklist 6/8
5Y Shares Out Change < 0%
ROIC > 10%
Debt/Equity < 1
Current Ratio > 1
Net Margin > 10%
Est. EPS Growth > 5%
Quick Ratio > 1
Past Net Income CAGR > 0%
0.0%of Portfolio
My holdings
Day change:
Total change:
Shares:Cost basis:
Market cap: $623.71(B)
EV: $705.56(B)
Total Equity: $81.19(B)
Earnings date: Jul-15-2026
P/E: 29.65
Forward P/E: 22.39
P/FCF: 35.06
P/S: 6.47
P/B: 7.68
EPS: $8.7
EPS (fwd): $11.6
FCF/share: $7.4
Revenue/share: $40.0
Book value/share: $33.7
ROIC: 21.7%
ROA: 13.5%
ROE: 33.6%
Debt/Equity: 0.68
Current Ratio: 1.00
Gross margin: 68.0%
Operating margin: 26.2%
Net margin: 21.8%
Dividend/share: $5.2
Div. yield: 2.01%
Growth Estimates
Revenue
CAGR: 6.9%FY+1$100.94(B)
FY+2(+6.7%)$107.70(B)
FY+3(+6.8%)$115.04(B)
FY+4(+6.7%)$122.79(B)
FY+5(+7.4%)$131.87(B)
Net Income
CAGR: 10.5%FY+1$28.22(B)
FY+2(+9.7%)$30.96(B)
FY+3(+9.8%)$34.00(B)
FY+4(+10.7%)$37.63(B)
FY+5(+11.8%)$42.07(B)
EPS
CAGR: 11.0%FY+1$11.57
FY+2(+10.0%)$12.73
FY+3(+10.2%)$14.03
FY+4(+11.2%)$15.60
FY+5(+12.4%)$17.54
FCF per share
CAGR: 7.5%FY+1$11.15
FY+2(+11.9%)$12.48
FY+3(+5.1%)$13.11
FY+4(+6.3%)$13.94
FY+5(+6.9%)$14.90
